Covid-19: Two more drugs recommended for use by WHO


A healthcare worker attaches an intravenous (IV) infusion for a monoclonal antibody treatment to a patient’s hand in the parking lot of a hospital in Detroit, United States. The WHO conditionally approved an additional monoclonal antibody to treat Covid-19, as well as another drug used to treat rheumatoid arthritis. — Bloomberg

The drug baricitinib is strongly recommended for patients with severe or critical Covid-19, in combination with corticosteroids, said a World Health Organization (WHO) Guideline Development Group of international experts in The BMJ medical journal on Jan 13 (2022).

Their strong recommendation is based on evidence of moderate certainty that it improves survival and reduces the need for ventilation, with no observed increase in adverse effects.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Health

Using an air gun to deliver vaccines
Plants can help remove indoor pollutants
Six stretches to ease your back pain
Here's a potentially cheap way to make water safe to drink
Are you a resilient person?
How to satisfy your food craving by just looking
When children experience dizziness and problems with balance
Signs your loved one might be a binge-eater
Involving the community when it comes to suicide prevention
What weeding and eating have in common

Others Also Read